Navigation Links
ReachMD XM 157 Announces Medical Information Feature on Irritable Bowel Syndrome, Its Treatments, and the Role of Probiotics
Date:6/30/2008

CHICAGO, June 30 /PRNewswire/ -- ReachMD XM 157 announces a new Medical Industry Feature of the Week highlighting functional GI disorders, current treatment options, and ways to build and maintain healthy digestive flora. This new programming will be sponsored by Procter & Gamble's ALIGN(R) brand.

ReachMD XM 157, the first and only network for medical professionals, will air the program entitled "Clinical Use of Probiotics in IBS" twice a day July 7-20. Healthcare professionals can tune in to XM Satellite Radio Channel 157 or listen online at http://www.ReachMD.com (Use promo code ALIGNPR)

The program features an interview with Emeran Mayer, MD, director of UCLA Center for Neurovisceral Sciences and Women's Health. Dr. Mayer authored the review article "Irritable Bowel Syndrome" recently published in the April 17, 2008 issue of The New England Journal of Medicine.

Dr. Mayer will be interviewed by program host Jeffrey Nathanson, MD, clinical instructor at Northwestern University's Feinberg School of Medicine. The topics include:

-- Digestive health - gastrointestinal disorders and bacteria balance

-- Irritable Bowel Syndrome (IBS) - statistics and facts, causes and

symptoms

-- General treatment alternatives

-- The potential role of probiotics - usage, clinical trials, and

accessibility to patients

The program is sponsored by Procter & Gamble in support of its new probiotic ALIGN dietary supplement, which helps build and maintain normal digestive health. As program sponsor, P&G will offer samples of ALIGN to health care professional listeners at the end of each show. Listeners will be able to call 888-55-ALIGN starting July 7 to request free samples and other product information.

Gary Epstein, CEO of ReachMD said, "We're proud to work with P&G to broadcast this very special program. Not only will this interview make for compelling radio, but also it will help physicians gain the latest information about this prevalent disorder and new approaches to treatment."

About P&G and ALIGN(R): Procter & Gamble has one of the strongest portfolios of trusted brands. ALIGN is an easy-to-swallow daily dietary supplement capsule that works naturally to help even out the ups and downs of common digestive upsets, such as constipation, diarrhea, abdominal discomfort, urgency, gas, and bloating. ALIGN capsules contain Bifantis, a unique probiotic strain. For more information, please visit http://www.AlignGI.com

About ReachMD XM 157: A leading provider of advanced healthcare information and education for medical professionals, ReachMD provides the most up to date healthcare information in the field through satellite radio, mobile phone, and online programs. These convenient and accessible technologies deliver the latest information in best practices and new advances in treatment to healthcare professionals. For more information, visit http://www.ReachMD.com


'/>"/>
SOURCE ReachMD
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio
2. AMA Foundation and ReachMD Collaborate to Broadcast Excellence in Medicine Awards
3. ReachMD Launches New Series on GI Issues
4. The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called The Strength to Heal That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio.
5. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
6. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
7. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
8. HEI, Inc. Announces Sale of RFID Division Assets
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
10. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
11. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... ... software, in partnership with Snowfall4pod Digital, creators of the gContentManager & Distribution ... content management, global distribution and print-on-demand network. , AVALANCHE allows enterprise customers ...
(Date:2/9/2016)... ... 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: BONT), which ... it has raised $176,000 to benefit the Breast Cancer Research Foundation, Froedtert & ... University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic Cancer Center ...
(Date:2/9/2016)... ... 09, 2016 , ... Two renowned photographers, Robert Caplin (New York, NY) and ... island, June 14-19, 2016, hosted by Four Seasons Resort Maui at Wailea as part ... debut in 2015, the Maui Photo Expedition workshop will once again consist ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... has officially been won. A team from 21st Century Medicine (21CM) ( http://www.21cm.com/ ... to preserve the delicate neural circuits of an intact rabbit brain for extremely ...
(Date:2/8/2016)... ... February 08, 2016 , ... Stephanie Hebert Insurance Agency, serving ... a new charity campaign. As part of their ongoing community involvement program, funds ... belief that children deserve a voice, and in the spirit of neighbors helping ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... 2016  Landauer, Inc. (NYSE: LDR ), a ... monitoring, outsourced medical physics services and high quality medical ... 2016 first quarter ended December 31, 2015. ... First Quarter Highlights , Revenue of $36.5 million ... 2015 , Domestic Radiation Measurement services revenues increased 2.8% ...
(Date:2/9/2016)... , February 9, 2016 ... gab heute den Abschluss eines Kooperationsvertrags mit ... umfassender Lösungen in den Bereichen Next-Generation-Sequencing (NGS), ... QGEN ; Frankfurt Prime Standard: QIA) gab ... Genomics für die Entwicklung und Förderung umfassender ...
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... disease and heart failure, today announced that it intends to ... stock in an underwritten public offering.  The offering is subject ... assurance as to whether or when the offering may be ... the offering.   --> --> ...
Breaking Medicine Technology: